Analysts/Institutional Investor Meet/Con. Call Updates

GLAND PHARMA LIMITED GLAND September 10, 2026 BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, 5th Floor 25th floor, Dalal Street Plot no. C-1, Block G, Bandra Kurla Complex Bandra Mumbai - 400 001 (East), Mumbai - 400 051 Scrip Code: 543245 Symbol: GLAND (ISIN: INE068V01023) Dear Sir/Madam, Sub: Intimation of Schedule of Analyst / Institutional Investor Meetings Pursuant to Regulation 30 read with Part A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; please find below the schedule of the Analyst/ Institutional Investor Meetings with the Company: Date Investor/Analyst/Fund Name Type of Meeting September 16, 2026 East Bridge Capital September 17, 2026 IIFL Capital One-on-One Meetings September 17, 2026 Antique Broking September 25, 2026 Group meeting arranged by Nomura Group Meeting The schedule of the above-mentioned meetings is subject to change, and the change may occur due to exigencies on the part of the Investor/ Analyst/ Company. This is for your information and records. Yours truly, For Gland Pharma Limited Sampath Kumar Pallerlamudi Company Secretary & Compliance Officer Regd. Office: Corporate Office: Survey No. 143-148, 150 & 151, Near Gandimaisamma 'X' Roads Plot No. 11 & 84, TSIIC Phase: IV D.P. Pally, Dundigal, Dundigal-Gandimaisamma Mandal Pashamylaram (V), Patancheru (M), Sangareddy District Medchal-Malkajgiri District, Hyderabad 500043,Telangana, India Hyderabad 502307, Telangana, India Tel: +91-40-30510999 Fax: +91 0-30510800 Tel: +91-8455-699999 CIN: L24239TG1978PLC002276 | email: gland@glandpharma.com; investors@glandpharma.com | www.glandpharma.com